Retrospective analysis of the last 10 years of dengue cases in São Francisco de Itabapoana city (RJ)
DOI:
https://doi.org/10.24859/SaberDigital.2025v18n2.1727Keywords:
Dengue, DENV1, DENV2, Social vulnerability, Public healthAbstract
Introduction: Dengue is an arboviral disease caused by the DENV virus. This virus has four antigenically distinct serotypes: DENV-1, DENV-2, DENV-3, and DENV-4. Serotypes DENV-1 and DENV-2 are believed to be circulating widely in South America. Data from the Institute of Health Information indicate that 302,457 confirmed cases of dengue were recorded in 2024 in the State of Rio de Janeiro. The municipality of São Francisco do Itabapoana is located in the northern Fluminense region of the state and also had an outbreak of dengue cases in the same year. Objective: carry out a historical analysis of dengue cases and notifications in the municipality from 2014 to 2024. Methodology: The data for this study were extracted from the Ministry of Health for the last 10 years, obtained from the following government platforms: Department of National Informatics, Brazilian Health System, Health Information, and Information System for Notifiable Diseases. Results: The data indicate that 4,910 cases of dengue fever have been reported in the municipality over the last 10 years. The year with the highest number of dengue fever cases was 2024, with 3,286 cases, which is equivalent to 66.92% of the cases in the historical curve. As for the serotype, the virus was identified in only two cases, one case in 2015 and another case in 2024, which is equivalent to 0.04% of the cases in the historical series, and the serotype tracked was DENV1. In a total of 4,908 cases, this information was ignored in 99.96%. Conclusion: We found a high rate of underreporting in several important parameters for the development of public policies for promotion, protection, and rehabilitation that prevent the understanding of dengue fever in the locality.
Downloads
References
ALVES, E.; DA SILVA, M.; OLIVEIRA, F.; SILVA, T. Social vulnerability to phosphoethanolamine based on the principlist theory. Rev. bioética, 27, n. 1, p. 173-178, 2019. DOI: https://doi.org/10.1590/1983-80422019271300
AMORIM, M. T.; NAVECA, F. G.; HERNANDEZ, L. H. A.; DA PAZ, T. Y. B. et al. Detection of a Multiple Circulation Event of Dengue Virus 2 Strains in the Northern Region of Brazil. Trop Med Infect Dis, 9, n. 1, Jan 9 2024. DOI: https://doi.org/10.3390/tropicalmed9010017
ANDRIOLI, D. C.; BUSATO, M. A.; LUTINSKI, J. A. Spatial and temporal distribution of dengue in Brazil, 1990 - 2017. PLoS One, 15, n. 2, p. e0228346, 2020. DOI: https://doi.org/10.1371/journal.pone.0228346
BOHM, A. W.; COSTA, C. D.; NEVES, R. G.; FLORES, T. R. et al. Dengue incidence trend in Brazil, 2002-2012. Epidemiol Serv Saude, 25, n. 4, p. 725-733, Oct-Dec 2016. DOI: https://doi.org/10.5123/S1679-49742016000400006
BRITO, A. F.; MACHADO, L. C.; OIDTMAN, R. J.; SICONELLI, M. J. L. et al. Lying in wait: the resurgence of dengue virus after the Zika epidemic in Brazil. Nat Commun, 12, n. 1, p. 2619, May 11 2021. DOI: https://doi.org/10.1038/s41467-021-22921-7
Censo 2022. https://censo2022.ibge.gov.br/panorama/ . Acesso: 11 de dezembro de 2024.
DA SILVA, M. H. A. Notification errors and underreporting of Covid-19 cases: Integrative review. Rev Saber Digital, 16, n. 3, p. e20231605, 2023. DOI: https://doi.org/10.24859/SaberDigital.2023v16n3.1464
DA SILVA, M. H. A.; DE SOUZA, J. A. Vulnerability of patients with prostatic hyperplasia treated with dutasteride and finasteride. Rev. Bioét., 29, n. 2, p. 394-400, 2021.
DA SILVA, M. H. A.; PROCÓPIO, I. M. The fragility of the Brazilian health system and social vulnerability in front of COVID-19. Rev Bras Promoç Saúde, 33, p. e10724, 2020. DOI: https://doi.org/10.5020/18061230.2020.10724
DA SILVEIRA, L. T. C.; TURA, B.; SANTOS, M. Systematic review of dengue vaccine efficacy. BMC Infect Dis, 19, n. 1, p. 750, Aug 28 2019. DOI: https://doi.org/10.1186/s12879-019-4369-5
DATASUS. Departamento de Informática da Nacional Brasileira Sistema de Saúde. https://datasus.saude.gov.br/. Acesso: 07 de agosto de 2024.
DE AZEVEDO, T. S.; LORENZ, C.; CHIARAVALLOTI-NETO, F. Spatiotemporal evolution of dengue outbreaks in Brazil. Trans R Soc Trop Med Hyg, 114, n. 8, p. 593-602, Aug 1 2020. DOI: https://doi.org/10.1093/trstmh/traa030
FAVIER, C.; DEGALLIER, N.; ROSA-FREITAS, M. G.; BOULANGER, J. P. et al. Early determination of the reproductive number for vector-borne diseases: the case of dengue in Brazil. Trop Med Int Health, 11, n. 3, p. 332-340, Mar 2006. DOI: https://doi.org/10.1111/j.1365-3156.2006.01560.x
FIGUEIREDO, L. T. Dengue in Brazil. Rev Soc Bras Med Trop, 45, n. 3, p. 285, Jun 2012. DOI: https://doi.org/10.1590/S0037-86822012000300001
JUNIOR, J. B. S.; MASSAD, E.; LOBAO-NETO, A.; KASTNER, R. et al. Epidemiology and costs of dengue in Brazil: a systematic literature review. Int J Infect Dis, 122, p. 521-528, Sep 2022. DOI: https://doi.org/10.1016/j.ijid.2022.06.050
LESSA, C. L. S.; HODEL, K. V. S.; GONCALVES, M. S.; MACHADO, B. A. S. Dengue as a Disease Threatening Global Health: A Narrative Review Focusing on Latin America and Brazil. Trop Med Infect Dis, 8, n. 5, Apr 23 2023. DOI: https://doi.org/10.3390/tropicalmed8050241
LOPES, T. R. R.; SILVA, C. S.; PASTOR, A. F.; SILVA JUNIOR, J. V. J. Dengue in Brazil in 2017: what happened? Rev Inst Med Trop Sao Paulo, 60, p. e43, Aug 20 2018. DOI: https://doi.org/10.1590/s1678-9946201860043
MACIAS, A. E.; WERNECK, G. L.; CASTRO, R.; MASCARENAS, C. et al. Mortality among Hospitalized Dengue Patients with Comorbidities in Mexico, Brazil, and Colombia. Am J Trop Med Hyg, 105, n. 1, p. 102-109, May 10 2021. DOI: https://doi.org/10.4269/ajtmh.20-1163
NOGUEIRA, R. M.; MIAGOSTOVICH, M. P.; CAVALCANTI, S. M.; MARZOCHI, K. B. et al. Levels of IgM antibodies against dengue virus in Rio de Janeiro, Brazil. Res Virol, 143, n. 6, p. 423-427, Nov-Dec 1992. DOI: https://doi.org/10.1016/S0923-2516(06)80136-6
NUNES, P. C. G.; DAUMAS, R. P.; SANCHEZ-ARCILA, J. C.; NOGUEIRA, R. M. R. et al. 30 years of fatal dengue cases in Brazil: a review. BMC Public Health, 19, n. 1, p. 329, Mar 21 2019. DOI: https://doi.org/10.1186/s12889-019-6641-4
ONEDA, R. M.; BASSO, S. R.; FRASSON, L. R.; MOTTECY, N. M. et al. Epidemiological profile of dengue in Brazil between the years 2014 and 2019. Rev Assoc Med Bras (1992), 67, n. 5, p. 731-735, Jun 2021. DOI: https://doi.org/10.1590/1806-9282.20210121
ROCHA, I. R.; LABRE-NASCIMENTO, G.; COSTA, E. S.; MATOS, D. P. et al. Estudo farmacoepidemiológico da venda e dos efeitos adversos da Oxicodona no Brasil: Revisão sistemática. Revista Saber Digital, 2, 17, p. e20241704, 2024. DOI: https://doi.org/10.24859/SaberDigital.2024v17n2.1520
SAÚDE-OMS, O. M. Estratégia Global de Vigilância Genómica para Patógenos com Potencial Pandêmico e Epidêmico 2022 -2032. 2022.
SCOTT, V. K.; PINHEIRO, M. S. N.; MACHADO, M. M. T.; CASTRO, M. C. Acceptability of a hypothetical dengue vaccine and the potential impact of dengue vaccination on personal vector control behavior: a qualitative study in Fortaleza, Brazil. BMC Public Health, 23, n. 1, p. 2408, Dec 4 2023. DOI: https://doi.org/10.1186/s12889-023-17005-8
DA SILVA, M. H. A. ; LABRE-NASCIMENTO, G. Health surveillance processes in Brasil. LAP Lambert Academic Publishing. London, Unites Kingdom. Cap 6. p47-64. 2024.
SOUZA, U. J. B.; MACEDO, Y.; SANTOS, R. N. D.; CARDOSO, F. D. P. et al. Circulation of Dengue Virus Serotype 1 Genotype V and Dengue Virus Serotype 2 Genotype III in Tocantins State, Northern Brazil, 2021-2022. Viruses, 15, n. 11, Oct 24 2023. DOI: https://doi.org/10.3390/v15112136
TABNET. Informações em Saúde. https://datasus.saude.gov.br/informacoes-de-saude-tabnet/ . Acesso em 07 de agosto de 2024.
TEIXEIRA, M. G.; COSTA MDA, C.; BARRETO, F.; BARRETO, M. L. Dengue: twenty-five years since reemergence in Brazil. Cad Saude Publica, 25 Suppl 1, p. S7-18, 2009. DOI: https://doi.org/10.1590/S0102-311X2009001300002
YENAMANDRA, S. P.; KOO, C.; CHIANG, S.; LIM, H. S. J. et al. Evolution, heterogeneity and global dispersal of cosmopolitan genotype of Dengue virus type 2. Sci Rep, 11, n. 1, p. 13496, Jun 29 2021. DOI: https://doi.org/10.1038/s41598-021-92783-y
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Revista Saber Digital
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Declaração de Direito Autoral
Autores que publicam na Revista Saber Digital concordam com os seguintes termos:
Os autores mantêm os direitos e cedem à revista o direito à primeira publicação, simultaneamente submetido a uma licença Creative Commons que permite o compartilhamento por terceiros com a devida menção ao autor e à primeira publicação pela Revista Saber Digital.
Os autores podem entrar em acordos contratuais adicionais e separados para a distribuição não exclusiva da versão publicada da obra (por exemplo, postá-la em um repositório institucional ou publicá-la em um livro), com o reconhecimento de sua publicação inicial na Revista Saber Digital.
Este obra está licenciado com uma Licença https://creativecommons.org/licenses/by-nc/4.0/
